Elevate Your Investing Strategy:
- Take advantage of TipRanks Premium at 50% off! Unlock powerful investing tools, advanced data, and expert analyst insights to help you invest with confidence.
An update from Colgate-Palmolive ( (CL) ) is now available.
On July 31, 2025, Colgate-Palmolive‘s Board of Directors approved a new three-year Strategic Growth and Productivity Program aimed at driving future growth and supporting its 2030 strategy. This initiative is expected to incur cumulative pre-tax charges of $200 to $300 million, with a significant portion allocated to employee-related costs and asset-related expenses. The program will impact various regions, including North America, Latin America, Europe, Asia Pacific, Africa/Eurasia, and Hill’s Pet Nutrition, with the majority of charges anticipated to be cash expenditures by December 31, 2028.
The most recent analyst rating on (CL) stock is a Hold with a $82.00 price target. To see the full list of analyst forecasts on Colgate-Palmolive stock, see the CL Stock Forecast page.
Spark’s Take on CL Stock
According to Spark, TipRanks’ AI Analyst, CL is a Neutral.
Colgate-Palmolive’s strong financial performance and strategic focus on innovation are key strengths, supporting a stable outlook. However, high leverage, bearish technical indicators, and moderate valuation temper the overall score.
To see Spark’s full report on CL stock, click here.
More about Colgate-Palmolive
Colgate-Palmolive is a leading consumer products company specializing in the production and distribution of oral care, personal care, home care, and pet nutrition products. The company focuses on global markets with a strong presence in North America, Latin America, Europe, Asia Pacific, and Africa/Eurasia.
Average Trading Volume: 5,603,274
Technical Sentiment Signal: Sell
Current Market Cap: $61.84B
For a thorough assessment of CL stock, go to TipRanks’ Stock Analysis page.